Analysis of the efficiency of retrocochlear screening
Authors:
Open Access
- 1 October 1992
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 102 (10) , 1108-1112
Abstract
The auditory brainstem response (ABR), as well as associated audiologic and radiographic studies of 175 patients suspected of having cerebellopontine angle tumors were reviewed. The majority of patients presented with asymmetric hearing loss. Eight acoustic neuromas were identified. All eight had abnormal ABRs. The false‐positive rate was 22%. Rollover and acoustic reflex testing played a minimal role in the decision as to whether or not an ABR was ordered and, as a result, are not important in the search for retrocochlear disease. The cost per tumor diagnosed was roughly $7600. A rational approach to tumor screening based on the efficiency and cost of the screening tests, the frequency of abnormal ABRs, and the cost per tumor diagnosed is presented.Keywords
This publication has 12 references indexed in Scilit:
- IMAGING PATIENTS WITH SUSPECTED ACOUSTIC NEUROMAThe Lancet, 1989
- Pitfalls in Neurotologic DiagnosisEar & Hearing, 1988
- Normal Hearing in Patients With Acoustic NeuromaSouthern Medical Journal, 1987
- Clinical Performance of Audiological and Related Diagnostic TestsEar & Hearing, 1984
- Acoustic tumorsNeurology, 1983
- Auditory Brain Stem Response Results from 255 Patients with Suspected Retrocochlear InvolvementEar & Hearing, 1982
- Diagnosis of acoustic neuromaNeurosurgery, 1981
- The acoustic reflex test in cochlear and eighth nerve pathology earsThe Laryngoscope, 1981
- Brainstem Auditory Evoked Potentials for Detection of Retrocochlear PathologyAnnals of Otology, Rhinology & Laryngology, 1980
- Auditory Test Results in 500 Cases of Acoustic NeuromaJAMA Otolaryngology–Head & Neck Surgery, 1977